tga bpc 157 approval australia A health warning about unregulated peptides has been issued by Australia's drug regulator but doctors say more action is needed. Reporting by national health equity reporters Caitlyn Gribbin and Rachel Carbonell, ABC RACGP - TGA issues warning

This poses serious health risks, including allergic reactions, infections (particularly with injectable products), or toxicity from unknown contaminants

The funds investment in shares of the Underlying ETFs subjects it to the risks of owning the securities held by the Underlying ETF, as well as the same structural risks faced by an investor purchasing shares of the fund

Jossy Onwude, MD Published Apr 16, 2026 24 min read The short version: On April 15, 2026, the FDA announced it will convene an advisory panel in July to review seven restricted peptides including BPC-157 and TB-500 and decide whether they can be legally compounded again

Prioritizing 7-9 hours of quality sleep supports the healing process that BPC-157 initiates at the cellular level